Renal Denervation Researcher Argues Sham Control Is Ethically Necessary

The lead investigator on the SYMPLICITY HTN-3 trial says sham-controlled trials are sometimes ethically necessary to prevent patients from undergoing ineffective treatments and warns there may be other medical devices on the market that are not as effective as previously thought.

More from Clinical Trials

More from R&D